223 related articles for article (PubMed ID: 365312)
1. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275).
Douglass HO; Lavin PT; Evans JT; Mittelman A; Carbone PP
Cancer Treat Rep; 1979 Aug; 63(8):1355-7. PubMed ID: 476709
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
5. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.
Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA
Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
[TBL] [Abstract][Full Text] [Related]
7. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Douglass HO; Lavin PT; Moertel CG
Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
Kemeny N; Yagoda A; Braun D; Golbey R
Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575
[TBL] [Abstract][Full Text] [Related]
9. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
[TBL] [Abstract][Full Text] [Related]
10. Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.
Moertel CG; Lavin PT
Cancer Treat Rep; 1979; 63(11-12):1863-9. PubMed ID: 393381
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracil.
Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
Cancer Treat Rep; 1978 Oct; 62(10):1603-5. PubMed ID: 361230
[TBL] [Abstract][Full Text] [Related]
12. Therapy of advanced colorectal carcinoma with 5-fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate.
White DR; Richards F; Muss HB; Cooper MR; Spurr CL
Cancer; 1980 Feb; 45(4):662-5. PubMed ID: 6986968
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
[TBL] [Abstract][Full Text] [Related]
14. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
[TBL] [Abstract][Full Text] [Related]
16. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer.
Brutti A; Liberati AM; Biscottini B; Fatati G; Sini S; Barzi AM; Grignani F
Tumori; 1979 Jun; 65(3):339-44. PubMed ID: 462584
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine.
Presant CA; Denes AE; Liu C; Bartolucci AA
Cancer; 1984 Jun; 53(12):2610-4. PubMed ID: 6372981
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
Belt RJ; Stephens R
Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
